Showing 131-140 of 355 grants
| Title | Institution | Researcher | Program | Duration | Total Award Amount |
|---|---|---|---|---|---|
| Inhibition of REDD1 Allostery as a Therapeutic for Type 1 Diabetes | Penn State College of Medicine | Michael Dennis | Improving Lives | 01-June-2024 to 31-May-2026 | $200,000.00 |
| Advancing Breakthroughs in Type 1 Diabetes Research with Safe and Immune Cloaked Stem Cells | Pluristyx | Benjamin Fryer | Cures | 15-November-2025 to 14-November-2027 | $704,860.20 |
| Assessing use of primary and secondary CVD prevention therapies in people with T1D and developing strategies to increase uptake | Putnam Associates | Thomas Marder | Improving Lives | 01-August-2026 to 31-July-2027 | $615,000.00 |
| T1D Disease-Modifying Therapy: Immunotherapy Landscape and Prioritization Framework | Quaestio Global Partners, LLC | Magdy Abdel-Malik | Cures | 06-July-2026 to 01-July-2027 | $69,999.00 |
| Clinical Validation of a Smart Bolus Calculator Informed by Insulin Sensitivity in Adults and Adolescents with Type 1 Diabetes | Rector & Visitors of the University of Virginia | Chiara Fabris | Improving Lives | 01-June-2020 to 30-June-2027 | $604,390.26 |
| Pancreatic Islet Transplantation for the Treatment of Type 1 Diabetes: In-Silico Developments to Support Clinical Advancements | Rector & Visitors of the University of Virginia | Chiara Fabris | Cures | 01-January-2025 to 31-December-2026 | $299,916.19 |
| Augmenting a clinical scaffold for long-term graft implantation | Rector & Visitors of the University of Virginia | Donald Griffin | Cures | 01-May-2026 to 30-April-2028 | $600,000.00 |
| Dual Beta-cell Regenerative and Immunomodulatory Endogenous Agonist as a Replacement Therapy for Type 1 Diabetes | Rector & Visitors of the University of Virginia | Gordon Laurie | Cures | 01-October-2025 to 30-September-2027 | $300,000.00 |
| Development of simulation tools to support adaptation of automated insulin delivery algorithms across pregnancies complicated by type 1 diabetes | Rector & Visitors of the University of Virginia | Jacopo Pavan | Improving Lives | 01-March-2025 to 28-February-2027 | $189,316.00 |
| Anti-CD71 immunotherapy to restore T cell homeostasis in autoimmunity | Rector & Visitors of the University of Virginia | Kelsey Voss | Cures | 01-September-2025 to 31-December-2026 | $150,000.00 |